drugset
drugset / Trial / NCT03100058

A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults

NCT03100058 ↗

Phase 2 Completed 460 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

This was a dose-finding study that evaluated the change in weight after 24 weeks treatment with 8 different doses of LIK066 compared to placebo in obese or overweight adults, followed by 24 weeks treatment with 2 doses of LIK066 and placebo.

Timeline

Start
2017-05-06
Primary completion
2018-03-02
Completion
2018-08-02

Drugs

EvaluationDrugModalityDoseRoute
Subject licogliflozin Small molecule 2.5 mg Oral
Subject licogliflozin Small molecule 5 mg Oral
Subject licogliflozin Small molecule 10 mg Oral
Subject licogliflozin Small molecule 25 mg Oral
Subject licogliflozin Small molecule 35 mg Oral
Subject licogliflozin Small molecule 50 mg Oral
Subject licogliflozin Small molecule 150 mg Oral

Indications

obesity disorder